These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38315890)

  • 1. Extensively Drug-Resistant Pseudomonas aeruginosa Outbreak Associated With Artificial Tears.
    Grossman MK; Rankin DA; Maloney M; Stanton RA; Gable P; Stevens VA; Ewing T; Saunders K; Kogut S; Nazarian E; Bhaurla S; Mephors J; Mongillo J; Stonehocker S; Prignano J; Valencia N; Charles A; McNamara K; Fritsch WA; Ruelle S; Plucinski CA; Sosa LE; Ostrowsky B; Ham DC; Walters MS;
    Clin Infect Dis; 2024 Jul; 79(1):6-14. PubMed ID: 38315890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensively Drug-Resistant Carbapenemase-Producing Pseudomonas aeruginosa and Medical Tourism from the United States to Mexico, 2018-2019.
    Kracalik I; Ham DC; McAllister G; Smith AR; Vowles M; Kauber K; Zambrano M; Rodriguez G; Garner K; Chorbi K; Cassidy PM; McBee S; Stoney RJ; Moser K; Villarino ME; Zazueta OE; Bhatnagar A; Sula E; Stanton RA; Brown AC; Halpin AL; Epstein L; Walters MS;
    Emerg Infect Dis; 2022 Jan; 28(1):51-61. PubMed ID: 34932447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
    McCracken MG; Adam HJ; Blondeau JM; Walkty AJ; Karlowsky JA; Hoban DJ; Zhanel GG; Mulvey MR;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv32-iv38. PubMed ID: 31505643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High mortality of bloodstream infection outbreak caused by carbapenem-resistant P. aeruginosa producing SPM-1 in a bone marrow transplant unit.
    Chaves L; Tomich LM; Salomão M; Leite GC; Ramos J; Martins RR; Rizek C; Neves P; Batista MV; Amigo U; Guimaraes T; Levin AS; Costa SF
    J Med Microbiol; 2017 Dec; 66(12):1722-1729. PubMed ID: 29095142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla
    PÉrez-VÁzquez M; Sola-Campoy PJ; Zurita ÁM; Ávila A; GÓmez-Bertomeu F; SolÍs S; LÓpez-Urrutia L; GÓnzalez-BarberÁ EM; Cercenado E; Bautista V; Lara N; Aracil B; Oliver A; Campos J; Oteo-Iglesias J;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106026. PubMed ID: 32450200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypes, carbapenemase carriage, integron diversity and oprD alterations among carbapenem-resistant Pseudomonas aeruginosa from Russia.
    Bocharova Y; Savinova T; Lazareva A; Polikarpova S; Gordinskaya N; Mayanskiy N; Chebotar I
    Int J Antimicrob Agents; 2020 Apr; 55(4):105899. PubMed ID: 31931151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nationwide genome surveillance of carbapenem-resistant
    Yano H; Hayashi W; Kawakami S; Aoki S; Anzai E; Zuo H; Kitamura N; Hirabayashi A; Kajihara T; Kayama S; Sugawara Y; Yahara K; Sugai M
    Antimicrob Agents Chemother; 2024 May; 68(5):e0166923. PubMed ID: 38564665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Features and Treatment Outcomes of Carbapenem-Resistant Pseudomonas aeruginosa Keratitis.
    Tribin FE; Lieux C; Maestre-Mesa J; Durkee H; Krishna K; Chou B; Neag E; Tóthová JD; Martinez JD; Flynn HW; Parel JM; Miller D; Amescua G
    JAMA Ophthalmol; 2024 May; 142(5):407-415. PubMed ID: 38512246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Carbapenem Resistance Mechanisms and Its Association with Pseudomonas aeruginosa Infections in the Northwest of Iran.
    Akhi MT; Khalili Y; Ghotaslou R; Yousefi S; Kafil HS; Naghili B; Sheikhalizadeh V
    Microb Drug Resist; 2018 Mar; 24(2):126-135. PubMed ID: 28654368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficult-to-treat (DTR)
    Vega AD; DeRonde K; Jimenez A; Piazza M; Vu C; Martinez O; Rojas LJ; Marshall S; Yasmin M; Bonomo RA; Abbo LM
    Antimicrob Agents Chemother; 2024 May; 68(5):e0147423. PubMed ID: 38602418
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of carbapenem-resistant Pseudomonas aeruginosa clinical isolates, carrying multiple genes coding for this antibiotic resistance.
    Rizek C; Fu L; Dos Santos LC; Leite G; Ramos J; Rossi F; Guimaraes T; Levin AS; Costa SF
    Ann Clin Microbiol Antimicrob; 2014 Sep; 13():43. PubMed ID: 25179208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of Ceftolozane-Tazobactam against Carbapenem-Resistant, Non-Carbapenemase-Producing Pseudomonas aeruginosa and Associated Resistance Mechanisms.
    Wi YM; Greenwood-Quaintance KE; Schuetz AN; Ko KS; Peck KR; Song JH; Patel R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29133568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Characterization of Carbapenemase-Producing Pseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread of Extensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-β-Lactamase.
    Papagiannitsis CC; Medvecky M; Chudejova K; Skalova A; Rotova V; Spanelova P; Jakubu V; Zemlickova H; Hrabak J;
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa in an endemic area: comparison with global data.
    Karampatakis T; Antachopoulos C; Tsakris A; Roilides E
    Eur J Clin Microbiol Infect Dis; 2018 Jul; 37(7):1211-1220. PubMed ID: 29644540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
    Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
    J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Characterization of Extended-Spectrum Beta Lactamase- and Carbapenemase-Producing Pseudomonas aeruginosa Strains from a Malaysian Tertiary Hospital.
    Phoon HYP; Hussin H; Hussain BM; Thong KL
    Microb Drug Resist; 2018 Oct; 24(8):1108-1116. PubMed ID: 29437541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.